300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
Africa
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Costa Rica
Colombia
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Prosperico Ventures, VC Fund

Prosperico Ventures

VC Fund

Shanghai, China

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

Total investments:
16
Last investment:
Lead investor:
25%

Last updated:

Industries Prosperico Ventures invests in

MedicalHealth CareBiotechnologyMedical DeviceDental

Stages Prosperico Ventures invests in

Series ASeedSeries BSeries CCorporate Round

Countries Prosperico Ventures invests in

ChinaUnited States

Round sizes

Series A $4.3M–$60MSeries B $9.2M–$150M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$4.3M–$60M
Series B
$9.2M–$150M

Investment Focus

Industry

  • Medical 8 (50%)
  • Health Care 7 (44%)
  • Biotechnology 6 (38%)
  • Medical Device 3 (19%)
  • Dental 1 (6%)
See all 17 industries →

Stage

  • Series A 8 (50%)
  • Seed 3 (19%)
  • Series B 3 (19%)
  • Series C 1 (6%)
  • Corporate Round 1 (6%)

Country

  • China 11 (69%)
  • United States 1 (6%)

Team

NameTitleInvestmentsLinksEmail
Tingzhi Qian
Tingzhi Qian President, Founding Partner
President, Founding Partner Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Antekin Biotech Antekin Biotech
Antekin Biotech is a leading vaccine company with integrated capabilities spanning the entire vaccine value chain, from research and development to manufacturing and commercialization. The company is dedicated to advancing innovative vaccine technologies, enhancing disease prevention, and delivering high-quality vaccine solutions to improve publichealth and address global healthcare challenges. $143.2M / Corporate Round / Jun 15, 2026
Yingte Micro Network
Yingte Micro Network is a medical device company focused on advancing innovation in energy-based therapeutic platforms and minimally invasive interventions, dedicated to improving patient outcomes through cutting-edge technology, precision engineering, and clinically proven solutions that enhance safety, efficiency, and recovery in modernhealthcare. Seed / Apr 07, 2026
Cytocares Cytocares
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity. $14.4M / Series A / May 13, 2023
Jiaohong Biology Jiaohong Biology
Jiaohong Biology is a molecular diagnostic technology research and development and application service provider. Seed / Jan 20, 2023
KingstronBio KingstronBio
KingstronBio manufactures artificial heart valves and annuloplasty rings. $47M / Series C / Nov 19, 2021
Singlera Genomics Singlera Genomics
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precisionmedicine, striving to help the patients through early, accurate and informative diagnoses. $150M / Series B / Dec 15, 2020
Silexon Silexon
Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening. Series A / Oct 17, 2019
Sealmed
Its main business scope is medical device technology development and sales; biomedical technology development, technology transfer, technical consulting services; corporate marketing planning; market research; business information consulting; Management consulting services; self-operated and agent import and export business of various commoditiesand technologies. Series A / Sep 16, 2019
InfiNovo InfiNovo
Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design. Series A / Apr 01, 2019
Wolfman Medical Technology (Forssmann) Wolfman Medical Technology (Forssmann)
Wolfman Medical Technology is a medical imaging equipment developer dedicated to medical imaging technology and brain Seed / Oct 16, 2018
See all 16 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
Africa
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Costa Rica
Colombia
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Prosperico Ventures invest in?

Prosperico Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Prosperico Ventures invest in?

Prosperico Ventures typically joins rounds of $4.3M–$60M at Series A and $9.2M–$150M at Series B. These are whole funding-round sizes, not Prosperico Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Prosperico Ventures took part in.

How do I contact Prosperico Ventures?

Public channels for Prosperico Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Prosperico Ventures?

The team at Prosperico Ventures includes Tingzhi Qian (President, Founding Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Prosperico Ventures Prosperico Ventures Find emails